EOM 1352: Fri 7 June 2024, 11:36

Current Edition

Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Europe

‘FDA should withdraw ANDAs’, and ‘new technologies could bring massive improvements in efficiency’ if implemented correctly

5 - 7 November 2019, Frankfurt, Germany.CPhI Worldwide - the world's largest pharma event taking place in Frankfurt - has released the first part of its eponymous 20...
Continue Reading →
Europe

New strategy to treat Parkinson’s disease

Northwestern Medicine scientists have used patient-derived neurons to develop and test a new strategy to treat Parkinson's disease by mitigating the effects of harmf...
Continue Reading →
Europe

German pharma benefiting from a Brexit boost?

Germany consolidates itself as world leader in pharma according to the CPhI Pharma Index Frankfurt, 24th October 2019: Research conducted by CPhI Worldwi...
Continue Reading →
Europe

Bayer launches LifeHub UK focused on artificial intelligence to optimize data-driven drug discovery and disease diagnosis

Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solution...
Continue Reading →
Europe

New evidence links 1970s pregnancy test drug to life-changing birth defects

There may have been a 'cover-up' of the effect of the drug on pregnant mothers, say campaigners. New evidence has emerged linking the hormone-based drug Primodos ...
Continue Reading →
Europe

Clovis’ Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn

Already behind in the PARP inhibitor race, Clovis Oncology’s Rubraca has won a boost with reserved backing from England’s drug cost watchdog that helps level th...
Continue Reading →
Europe

Teva, J&J make multibillion-dollar settlement offers as opioid trial gets going

After months of waiting, one drugmaker and five distributors accused of fueling the nation’s opioid addiction epidemic may finally face a courtroom this week. But wi...
Continue Reading →
Europe

Abbott and Omada Health partner to offer integrated digital health and coaching experience for people with Type 2 diabetes

Abbott (NYSE: ABT) and Omada Health announced today they are partnering to integrate Abbott's revolutionary FreeStyle Libre system, a continuous glucose monitoring ...
Continue Reading →
Europe

AI could offer warnings about serious side effects of drug-drug interactions

The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term orga...
Continue Reading →
Europe

New strategy to treat Parkinson’s disease

Northwestern Medicine scientists have used patient-derived neurons to develop and test a new strategy to treat Parkinson's disease by mitigating the effects of harm...
Continue Reading →
Catalyst: 12th January 2026
Quotient